BioWorld

March 31, 2003

Synta Steps Out Of The Shadows With $75.3M Funding For Pipeline

On its website, Synta Pharmaceuticals Inc. bills itself as the newest 10-year-old pharma firm in Boston. (BioWorld Today) Read More

Regeneron, Novartis Enter $75M Deal For IL-1 Trap Technology

Transgenic Mice Generated With Mutant Phosphorylated Synapse Test Retention Of Spatial Memory

Merck Data On Erbitux Status Appear Positive For ImClone

Acadia Raises $25M Privately To Advance Multiple Programs

Antex Filing For Bankruptcy After BioPort Buyout Fizzles

Procyon Acquiring Pharmacor If It Completes Funding Round

Other News To Note

Correction

NIH changes set industry up for workforce, ideas drought

BioWorld

On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...

Today's news in brief

BioWorld

BioWorld briefs for March 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for March 12, 2025

At CROI, HIV cure trials raise hopes for broader applicability

BioWorld

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...

Hummingbird migrates ADCs, tech to newco Callio’s $187M debut

BioWorld

Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...